Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders (Q37444808)

20 August 2017

1 reference

title

Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders (English)

1 reference

20 August 2017

0 references

0 references

0 references

0 references

1 reference

Brian F Thomas

2

0 references

Lance R McMahon

object named as

Lance R McMahon

series ordinal

3

0 references

author name string

Patrick M Beardsley

series ordinal

1

1 reference

20 August 2017

1 April 2009

1 reference

International Review of Psychiatry

20 August 2017

1 reference

20 August 2017

21

1 reference

20 August 2017

2

1 reference

20 August 2017

134-142

1 reference

Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.

20 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

A cannabinoid mechanism in relapse to cocaine seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid effects on behaviors maintained by ethanol or food: a within-subjects comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Synaptic plasticity and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The endogenous cannabinoid system modulates nicotine reward and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260902782786

10.1080/09540260902782786

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19367507